Valuation: Cello Health plc

Market Cap 179M 157M 146M 134M 252M 17.15B 256M 1.74B 679M 8.47B 671M 657M 29.27B P/E 2018
18.1x
P/E 2019 -155x
Enterprise Value 182M 160M 149M 137M 257M 17.49B 261M 1.77B 693M 8.64B 685M 670M 29.86B EV / Sales 2018
0.66x
EV / Sales 2019 0.88x
Free-Float
-
Yield 2018
3.47%
Yield 2019 1.6%
Manager TitleAgeSince
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 51 13/08/2020
Director/Board Member 47 15/12/2023
Date Insider Type Main position Quantity % Market Cap.
30/03/20 Free

Chief Financial Officer

250,000 0.2351%
30/03/20 Free

Controller/Auditor

80,000 0.0752%
30/03/20 Free

Founder

495,000 0.4656%

Financials

2018 2019
Net sales 166M 146M 135M 124M 234M 15.88B 237M 1.61B 629M 7.84B 622M 608M 27.1B 167M 147M 136M 125M 235M 15.99B 238M 1.62B 634M 7.9B 626M 613M 27.3B
Net income 6.62M 5.82M 5.42M 4.97M 9.34M 635M 9.46M 64.37M 25.14M 313M 24.84M 24.31M 1.08B -943K -829K -772K -709K -1.33M -90.43M -1.35M -9.17M -3.58M -44.65M -3.54M -3.46M -154M
Net Debt -6.34M -5.57M -5.19M -4.77M -8.95M -608M -9.07M -61.68M -24.09M -300M -23.8M -23.29M -1.04B 3.58M 3.14M 2.93M 2.69M 5.05M 343M 5.11M 34.79M 13.59M 169M 13.43M 13.14M 585M
Logo Cello Health plc
Cello Health plc, formerly Cello Group plc, is a United Kingdom-based healthcare and consumer strategic marketing company. The Company is engaged in providing market research, consulting and direct marketing services. The Company provides a range of biotech, diagnostics, devices and other non-healthcare clients. The Company operates through two segments: Cello Health and Cello Signal. The Cello Health Division provides market research, consulting and communications services principally to the Company's pharmaceutical and healthcare clients. The Cello Signal Division provides market research and direct communications services to the Company's consumer facing clients. The Company delivers its services from office networks in the United Kingdom, the United States and Singapore.
Employees
-
Sector
-